The Role of Intranasal Oxytocin in Anxiety and Depressive Disorders: A Systematic Review of Randomized Controlled Trials

키워드

참고문헌 (71)

1. Feldman R, "Evidence for a neuroendocrinological foundation of human affiliation : plasma oxytocin levels across pregnancy and the postpartum period predict mother-infant bonding", Psychol Sci, 18, pp.965~970 (2007)
2. Levine A, "Oxytocin during pregnancy and early postpartum : individual patterns and maternal-fetal attachment", Peptides, 28, pp.1162~1169 (2007)
3. Rocchetti M, "Neurofunctional maps of the 'maternal brain' and the effects of oxytocin : a multimodal voxel-based meta-analysis", Psychiatry Clin Neurosci, 68, pp.733~751 (2014)
4. Feeser M, "Oxytocin improves mentalizing-pronounced effects for individuals with attenuated ability to empathize", Psychoneuroendocrinology, 53, pp.223~232 (2015)
5. Radke S, "Does oxytocin affect mind-reading? A replication study", Psychoneuroendocrinology, 60, pp.75~81 (2015)
6. Bartz JA, "Oxytocin selectively improves empathic accuracy", Psychol Sci, 21, pp.1426~1428 (2010)
7. Brondino N, "Something to talk about : gossip increases oxytocin levels in a near real-life situation", Psychoneuroendocrinology, 77, pp.218~224 (2017)
8. Guastella AJ, "Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders", Biol Psychiatry, 67, pp.692~694 (2010)
9. Lischke A, "Intranasal oxytocin enhances emotion recognition from dynamic facial expressions and leaves eye-gaze unaffected", Psychoneuroendocrinology, 37, pp.475~481 (2012)
10. Domes G, "Oxytocin improves"mind-reading"in humans", Biol Psychiatry, 61, pp.731~733 (2007)
11. Pedersen CA, "Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia", Schizophr Res, 132, pp.50~53 (2011)
12. Williams DR, "Effects of intranasal oxytocin on symptoms of schizophrenia : A multivariate Bayesian metaanalysis", Psychoneuroendocrinology, 75, pp.141~151 (2017)
13. Rutigliano G, "Peripheral oxytocin and vasopressin : Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis", Psychiatry Res, 241, pp.207~220 (2016)
14. Stoop R, "Neuromodulation by oxytocin and vasopressin", Neuron, 76, pp.142~159 (2012)
15. Hashimoto H, "Pathophysiological function of oxytocin secreted by neuropeptides : a mini review", Pathophysiology, 19, pp.283~298 (2012)
16. Neumann ID, "Balance of brain oxytocin and vasopressin : implications for anxiety, depression, and social behaviors", Trends Neurosci, 35, pp.649~659 (2012)
17. Slattery DA, "No stress please! Mechanisms of stress hyporesponsiveness of the maternal brain", J Physiol, 586, pp.377~385 (2008)
18. Waldherr M, "Centrally released oxytocin mediates mating-induced anxiolysis in male rats", Proc Natl Acad Sci U S A, 104, pp.16681~16684 (2007)
19. Nyuyki KD, "Yes, I am ready now : differential effects of paced versus unpaced mating on anxiety and central oxytocin release in female rats", PLoS One, 6, pp.e23599~ (2011)
20. Neumann ID, "Oxytocin in general anxiety and social fear : a translational approach", Biol psychiatry, 79, pp.213~221 (2016)
21. Matsuzaki M, "Oxytocin : a therapeutic target for mental disorders", J Physiol Sci, 62, pp.441~444 (2012)
22. McQuaid RJ, "Making room for oxytocin in understanding depression", Neurosci Biobehav Rev, 45, pp.305~322 (2014)
23. Di Simplicio M, "Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers", J Psychopharmacol, 23, pp.241~248 (2009)
24. Baskerville TA, "Dopamine and oxytocin interactions underlying behaviors : potential contributions to behavioral disorders", CNS Neurosci Ther, 16, pp.e92~ (2010)[DOI]
25. Kroll-Desrosiers AR, "Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year", Depress Anxiety, 34, pp.137~146 (2017)
26. Bell AF, "Interaction between oxytocin receptor DNA methylation and genotype is associated with risk of postpartum depression in women without depression in pregnancy", Fron Genet, 6, pp.243~ (2015)
27. Stuebe AM, "Association between maternal mood and oxytocin response to breastfeeding", J Womens Health(Larchmt), 22, pp.352~361 (2013)
28. Moher D, "Preferred reporting items for systematic reviews and meta-analyses : the PRISMA Statement", Open Med, 3, pp.e123~ (2009)[DOI]
29. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders" (2013), APA Press
30. Higgins JPT, "The Cochrane collaboration’s tool for assessing risk of bias in randomised trials", BMJ, 343, pp.d5928~ (2011)
31. Fang A, "Attachment style moderates the effects of oxytocin on social behaviors and cognitions during social rejection : applying an RDoC framework to social anxiety", Clin Psychol Sci, 2, pp.740~747 (2014)
32. Fang A, "Working hard for oneself or others : Effects of oxytocin on reward motivation in social anxiety disorder", Biol Psychol, 127, pp.157~162 (2017)
33. Guastella AJ, "A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder", Psychoneuroendocrinology, 34, pp.917~923 (2009)
34. Dodhia S, "Modulation of resting-state amygdala-frontal functional connectivity by oxytocin in generalized social anxiety disorder", Neuropsychopharmacology, 39, pp.2061~2069 (2014)
35. Gorka SM, "Oxytocin modulation of amygdala functional connectivity to fearful faces in generalized social anxiety disorder", Neuropsychopharmacology, 40, pp.278~286 (2015)
36. Labuschagne I, "Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder", Neuropsychopharmacology, 35, pp.2403~2413 (2010)
37. Labuschagne I, "Medial frontal hyperactivity to sad faces in generalized social anxiety disorder and modulation by oxytocin", Int J Neuropsychopharmacol, 15, pp.883~896 (2012)
38. Acheson DT, "Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response", Depress Anxiety, 32, pp.400~407 (2015)
39. Klorman R, "Psychometric description of some specific-fear questionnaires", Behav Ther, 5, pp.401~409 (1974)
40. Szymanski J, "Fear of Spiders Questionnaire", J Behav Ther Exp Psychiatry, 26, pp.31~34 (1995)
41. Guy W, "ECDEU assessment manual for psychopharmacology" (1976), US Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration
42. Turner SM, "SPAI Manual" (1996), Multi-Health Systems
43. Liebowitz MR, "Social phobia", Mod Probl Pharmacopsychiatry, 22, pp.141~173 (1987)
44. Mark RL, "A brief version of the fear of negative evaluation scale", Personal Soc Psychol Bull, 9, pp.371~375 (1983)
45. Rapee RM, "Mental representation of observable attributes in people with social phobia", J Behav Ther Exp Psychiatry, 37, pp.113~126 (2006)
46. Spielberg CD, "STAI manual for the State-Trait Anxiety Inventory" (1970), Consulting Psychologists Press
47. Watson D, "Development and validation of brief measures of positive and negative affect : the PANAS scales", J Pers Soc Psychol, 54, pp.1063~1070 (1988)
48. Bond A, "The use of analogue scales in rating subjective feelings", Br J Med Psychol, 47, pp.211~218 (1974)
49. McNair DM, "Manual for the profile of mood states" (1971), Educational and Industrial Testing Service
50. Williams KD, "Cyberostracism : effects of being ignored over the Internet", J Pers Soc Psychol, 79, pp.748~762 (2000)
51. Williams KD, "Cyberball : a program for use in research on interpersonal ostracism and acceptance", Behav Res Methods, 38, pp.174~180 (2006)
52. Posner MI, "Orienting of attention", Q J Exp Psychol, 32, pp.3~25 (1980)
53. Posner MI, "Attention and the detection of signals", J Exp Psychol, 109, pp.160~174 (1980)
54. Treadway MT, "Worth the ‘EEfRT’? The effort expenditure for rewards task as an objective measure of motivation and anhedonia", PLoS ONE, 4, pp.e6598~ (2009)
55. Rapee RM, "Discrepancy between self-and observer ratings of performance in social phobics", J Abnorm Psychol, 101, pp.728~731 (1992)
56. Mochcovitch MD, "A systematic review of fMRI studies in generalized anxiety disorder : Evaluating its neural and cognitive basis", J Affect Disord, 167, pp.336~342 (2014)
57. Stein MB, "Increased amygdala and insula activation during emotion processing in anxiety-prone subjects", Am J Psychiatry, 164, pp.318~327 (2007)
58. Shin LM, "The neurocircuitry of fear, stress, and anxiety disorders", Neuropsychopharmacology, 35, pp.169~191 (2010)
59. Sripada CS, "Oxytocin enhances resting-state connectivity between amygdala and medial frontal cortex", Int J Neuropsychopharmacol, 16, pp.255~260 (2013)
60. Clarici A, "Intranasal adminsitration of oxytocin in postnatal depression : implications for psychodynamic psychotherapy from a randomized double-blind pilot study", Front Psychol, 6, pp.426~ (2015)
61. Cox JL, "Detection of postnatal depression. Development of the 10-item Edinburgh postnatal depression scale", Br J Psychiatry, 150, pp.782~786 (1987)
62. Hamilton M, "Development of a rating scale for primary depressive illness", Br J Soc Clin Psychol, 6, pp.278~296 (1967)
63. Mah BL, "Oxytocin in postnatally depressed mothers : its influence on mood and expressed emotion", Prog Neuropsychopharmacol Biol Psychiatry, 40, pp.267~272 (2013)
64. MacDonald K, "Oxytocin and psychotherapy : a pilot study of its physiological, behavioral and subjective effects in males with depression", Psychoneuroendocrinology, 38, pp.2831~2843 (2013)
65. Pincus D, "Inverse effects of oxytocin on attributing mental activity to others in depressed and healthy subjects : a double-blind placebo controlled FMRI study", Front Psychiatry, 1, pp.134~ (2010)
66. Domes G, "The effect of oxytocin on attention to angry and happy faces in chronic depression", BMC Psychiatry, 16, pp.92~ (2016)
67. Mah BL, "Oxytocin promotes protective behavior in depressed mothers : a pilot study with the enthusiastic stranger paradigm", Depress Anxiety, 32, pp.76~81 (2015)
68. Mah BL, "The effects of intranasal oxytocin administration on sensitive caregiving in mothers with postnatal depression", Child Psychiatry Hum Dev, 48, pp.308~315 (2017)
69. MacDonald E, "A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research", Psychoneuroendocrinology, 36, pp.1114~1126 (2011)
70. Alessandro Serretti, "The Present and Future of Precision Medicine in Psychiatry: Focus on Clinical Psychopharmacology of Antidepressants", Clinical Psychopharmacology and Neuroscience, 16(1), pp.1~6 (2018), 대한정신약물학회[DOI]
71. Churchland PS, "Modulating social behavior with oxytocin : how does it work? What does it mean", Horm Behav, 61, pp.392~399 (2012)

관련 논문AI추천